BullFrog AI Holdings
  • Home
  • About
  • Our Technology
  • Our Solution
  • News/Press
  • Contact

News and Press

August 7, 2019

BullFrog AI Signs Memorandum of Understanding with KBP Biosciences

BullFrog AI Innovative Artificial Intelligence Technology to Help Expand KBP’s Diverse Product Pipeline BALTIMORE – AUGUST 07, 2019 BullFrog AI specializes in helping pharmaceutical companies predict which patients will respond to…

Continue Reading

For media inquiries, please contact:

Liz Thibodeau
Thibodeau Media Group
Liz@thibmedia.com

Recent Articles

  • BullFrog AI and TTi Health Research & Economics Announce Partnership
  • BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development
  • BullFrog AI Secures $200K from TEDCO’s Seed Fund
  • BullFrog AI Signs Memorandum of Understanding with KBP Biosciences
  • BullFrog AI Announces New Chief Technology Officer

Archives

  • May 2020
  • April 2020
  • August 2019
  • December 2018
  • February 2018
  • October 2017

About BullFrog AI Holdings

Using the bfLeapTM Artificial Intelligence platform, BullFrog AI IP, a wholly owned subsidiary of Bullfrog AI Holdings that holds all of the intellectual property of the organization, specializes in helping pharmaceutical companies predict which patients will respond to therapies in development.

Contact

BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithersburg, MD 20878

info@bullfrogai.com

Google Tracking Code

Connect

© 2021 BullFrog AI Holdings. – Powered by DMVG Technology

    • Home
    • About
    • Our Technology
    • Our Solution
    • News/Press
    • Contact